Observational studyMedical science monitor : international medical journal of experimental and clinical research2017

The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy.

Sabrina Giacoppo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.